Clinical Trial Update: Topical Liposomal Amphotericin B Gel Treatment for Cutaneous Leishmaniasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical liposomal amphotericin B gel for cutaneous leishmaniasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leishmaniasis

Drugs mentioned

• liposomal amphotericin B gel (liposomal amphotericin B)

Snippet

Sponsor: Soroka University Medical Center | Conditions: Leishmaniasis | Phase 2 | Status: COMPLETED